Debomoy K Lahiri Selected Research

Debomoy K Lahiri Research Topics

Disease

115	Alzheimer Disease (Alzheimer's Disease) 05/2024 - 01/2002
26	Amyloid Plaque 03/2024 - 01/2002
18	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2024 - 03/2002
13	Neuroblastoma 12/2019 - 11/2002
11	Inflammation (Inflammations) 01/2024 - 11/2002
10	Parkinson Disease (Parkinson's Disease) 05/2024 - 12/2004
9	Neuroinflammatory Diseases 01/2019 - 12/2004
7	Dementia (Dementias) 03/2024 - 01/2002
7	Stroke (Strokes) 11/2015 - 11/2002
6	Disease Progression 08/2022 - 07/2005
6	Autistic Disorder (Autism) 01/2019 - 06/2006
4	Type 2 Diabetes Mellitus (MODY) 05/2024 - 03/2002
4	Memory Disorders (Memory Loss) 09/2019 - 02/2010
4	Neoplasms (Cancer) 01/2013 - 11/2003
3	Down Syndrome (Down's Syndrome) 03/2024 - 01/2013
3	Cognitive Dysfunction 01/2024 - 07/2009
3	Autism Spectrum Disorder 01/2023 - 12/2014
3	Hypoxia (Hypoxemia) 01/2018 - 12/2004
3	Fragile X Syndrome (Martin Bell Syndrome) 01/2016 - 07/2013
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2023 - 02/2014
2	Bipolar Disorder (Manic Depressive Psychosis) 12/2019 - 05/2015
2	Infarction (Infarctions) 11/2015 - 03/2007
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2012 - 12/2004
2	Erythema Nodosum 01/2004 - 11/2003
1	Nervous System Diseases (Neurological Disorders) 05/2024
1	Weight Loss (Weight Reduction) 05/2024
1	Obesity 05/2024
1	Frontotemporal Dementia (Semantic Dementia) 05/2024

Drug/Important Bio-Agent (IBA)

56	Proteins (Proteins, Gene)FDA Link 05/2024 - 03/2002
43	Amyloid (Amyloid Fibrils)IBA 03/2024 - 05/2004
41	Amyloid beta-PeptidesIBA 01/2017 - 01/2002
35	Peptides (Polypeptides)IBA 03/2024 - 01/2002
12	CytokinesIBA 01/2018 - 01/2004
9	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 03/2020 - 01/2006
7	IronIBA 01/2013 - 11/2002
6	Glucagon-Like Peptide 1 (GLP 1)IBA 05/2024 - 03/2002
6	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2020 - 08/2003
6	Messenger RNA (mRNA)IBA 01/2019 - 08/2002
6	phenserineIBA 01/2018 - 12/2004
6	Apolipoproteins E (ApoE)IBA 11/2015 - 01/2004
6	Cholinergic Agents (Cholinergics)IBA 01/2014 - 11/2005
6	Amyloid beta-Protein Precursor (Amyloid Protein Precursor)IBA 02/2010 - 10/2002
5	tau Proteins (tau Protein)IBA 12/2021 - 04/2011
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 11/2003
5	ApolipoproteinsIBA 01/2010 - 01/2004
5	MetalsIBA 07/2009 - 08/2004
4	RNA (Ribonucleic Acid)IBA 01/2024 - 08/2002
4	MicroRNAs (MicroRNA)IBA 01/2024 - 01/2012
4	Rivastigmine (Exelon)FDA LinkGeneric 03/2020 - 01/2002
4	EnzymesIBA 02/2014 - 06/2004
4	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2014 - 11/2005
4	VaccinesIBA 06/2013 - 08/2004
4	5' Untranslated Regions (5' UTR)IBA 01/2013 - 08/2002
3	Glucagon-Like Peptide-1 Receptor AgonistsIBA 05/2024 - 12/2004
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2011
3	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 10/2021 - 01/2002
3	LipopolysaccharidesIBA 01/2018 - 05/2012
3	CholesterolIBA 11/2015 - 08/2004
3	ButyrylcholinesteraseIBA 01/2014 - 01/2002
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 07/2013 - 06/2006
3	Glutamic Acid (Glutamate)FDA Link 07/2012 - 12/2004
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 07/2012 - 01/2010
3	Memantine (Namenda)FDA Link 07/2012 - 01/2010
3	DNA (Deoxyribonucleic Acid)IBA 06/2012 - 11/2002
3	Cholinesterases (Cholinesterase)IBA 07/2010 - 07/2005
3	Glucagon-Like Peptide-1 ReceptorIBA 01/2010 - 03/2002
3	Glucose (Dextrose)FDA LinkGeneric 01/2009 - 03/2002
3	CopperIBA 12/2008 - 05/2004
3	AcetylcholinesteraseIBA 07/2007 - 11/2005
3	Neuroprotective AgentsIBA 01/2007 - 11/2002
3	MelatoninIBA 11/2005 - 05/2004
3	Vaccinia virus complement-control proteinIBA 12/2004 - 11/2002
2	Insulin (Novolin)FDA Link 05/2024 - 03/2002
2	GlucocorticoidsIBA 01/2018 - 01/2018
2	Amyloidogenic ProteinsIBA 01/2015 - 02/2005
2	Acamprosate (Campral)FDA Link 12/2014 - 07/2013
2	Intravenous Immunoglobulins (IVIG)FDA Link 07/2014 - 01/2014
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2014 - 11/2005
2	Clioquinol (Vioform)FDA Link 06/2013 - 11/2002
2	Transcription Factors (Transcription Factor)IBA 01/2013 - 12/2004
2	N-Methylaspartate (NMDA)IBA 07/2012 - 01/2010
2	ElementsIBA 06/2012 - 07/2009
2	Exenatide (Byetta)FDA Link 01/2012 - 03/2002
2	Membrane Proteins (Integral Membrane Proteins)IBA 05/2011 - 02/2006
2	CurcuminIBA 01/2011 - 08/2009
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2011 - 04/2006
2	PhysostigmineIBA 07/2010 - 02/2005
2	Chelating AgentsIBA 07/2009 - 11/2002
2	Blood Glucose (Blood Sugar)IBA 01/2009 - 06/2003
2	ZincIBA 12/2008 - 08/2004
2	CarbamatesIBA 01/2007 - 02/2005
2	Complement System Proteins (Complement)IBA 12/2004 - 11/2002
2	Nitric Oxide Synthase (NO Synthase)IBA 12/2004 - 12/2004
2	Thalidomide (Thalomid)FDA Link 01/2004 - 11/2003
1	IncretinsIBA 03/2024
1	Sitagliptin Phosphate (Januvia)FDA Link 03/2024
1	Monoclonal AntibodiesIBA 03/2024

Therapy/Procedure

10	Therapeutics 12/2023 - 01/2002
2	Oral Administration 03/2024 - 12/2023
1	Drug Therapy (Chemotherapy) 03/2024